We have shown that in HIV infected children with definite or probable TB in whom an IFN-γ ELISpot assay is positive at presentation, anti-tuberculous treatment is accompanied by a reduction in IFN-γ responses to MTB-specific antigens. This evidence concerns the gene IFNG and tuberculosis.